Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) Enterprise Value (2016 - 2025)

Prestige Consumer Healthcare has reported Enterprise Value over the past 16 years, most recently at -$62.4 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$62.4 million for Q4 2025, down 22.6% from a year ago — trailing twelve months through Dec 2025 was -$62.4 million (down 22.6% YoY), and the annual figure for FY2025 was -$97.9 million, down 110.64%.
  • Enterprise Value for Q4 2025 was -$62.4 million at Prestige Consumer Healthcare, up from -$119.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for PBH hit a ceiling of -$21.0 million in Q4 2021 and a floor of -$163.6 million in Q2 2021.
  • Median Enterprise Value over the past 5 years was -$53.1 million (2023), compared with a mean of -$64.5 million.
  • Peak annual rise in Enterprise Value hit 78.08% in 2022, while the deepest fall reached 310.88% in 2022.
  • Prestige Consumer Healthcare's Enterprise Value stood at -$21.0 million in 2021, then crashed by 310.88% to -$86.4 million in 2022, then grew by 26.34% to -$63.6 million in 2023, then grew by 20.03% to -$50.9 million in 2024, then dropped by 22.6% to -$62.4 million in 2025.
  • The last three reported values for Enterprise Value were -$62.4 million (Q4 2025), -$119.1 million (Q3 2025), and -$139.5 million (Q2 2025) per Business Quant data.